دورية أكاديمية
Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine
| العنوان: | Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine |
|---|---|
| المؤلفون: | Hideaki Kaneto, Tomohiko Kimura, Masashi Shimoda, Atsushi Obata, Junpei Sanada, Yoshiro Fushimi, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku |
| المصدر: | International Journal of Molecular Sciences; Volume 22; Issue 15; Pages: 7917 |
| بيانات النشر: | Multidisciplinary Digital Publishing Institute |
| سنة النشر: | 2021 |
| المجموعة: | MDPI Open Access Publishing |
| مصطلحات موضوعية: | pancreatic β-cells, glucose toxicity, arteriosclerosis, GLP-1 receptor agonist, incretin-based medicine |
| جغرافية الموضوع: | agris |
| الوصف: | Fundamental pancreatic β-cell function is to produce and secrete insulin in response to blood glucose levels. However, when β-cells are chronically exposed to hyperglycemia in type 2 diabetes mellitus (T2DM), insulin biosynthesis and secretion are decreased together with reduced expression of insulin transcription factors. Glucagon-like peptide-1 (GLP-1) plays a crucial role in pancreatic β-cells; GLP-1 binds to the GLP-1 receptor (GLP-1R) in the β-cell membrane and thereby enhances insulin secretion, suppresses apoptotic cell death and increase proliferation of β-cells. However, GLP-1R expression in β-cells is reduced under diabetic conditions and thus the GLP-1R activator (GLP-1RA) shows more favorable effects on β-cells at an early stage of T2DM compared to an advanced stage. On the other hand, it has been drawing much attention to the idea that GLP-1 signaling is important in arterial cells; GLP-1 increases nitric oxide, which leads to facilitation of vascular relaxation and suppression of arteriosclerosis. However, GLP-1R expression in arterial cells is also reduced under diabetic conditions and thus GLP-1RA shows more protective effects on arteriosclerosis at an early stage of T2DM. Furthermore, it has been reported recently that administration of GLP-1RA leads to the reduction of cardiovascular events in various large-scale clinical trials. Therefore, we think that it would be better to start GLP-1RA at an early stage of T2DM for the prevention of arteriosclerosis and protection of β-cells against glucose toxicity in routine medical care. |
| نوع الوثيقة: | text |
| وصف الملف: | application/pdf |
| اللغة: | English |
| العلاقة: | Molecular Endocrinology and Metabolism; https://dx.doi.org/10.3390/ijms22157917Test |
| DOI: | 10.3390/ijms22157917 |
| الإتاحة: | https://doi.org/10.3390/ijms22157917Test |
| حقوق: | https://creativecommons.org/licenses/by/4.0Test/ |
| رقم الانضمام: | edsbas.AAB6FE0 |
| قاعدة البيانات: | BASE |
| ResultId |
1 |
|---|---|
| Header |
edsbas BASE edsbas.AAB6FE0 927 3 Academic Journal academicJournal 926.820373535156 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsbas&AN=edsbas.AAB6FE0&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://doi.org/10.3390/ijms22157917# [Name] => EDS - BASE [Category] => fullText [Text] => View record in BASE [MouseOverText] => View record in BASE ) ) |
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Hideaki+Kaneto%22">Hideaki Kaneto</searchLink><br /><searchLink fieldCode="AR" term="%22Tomohiko+Kimura%22">Tomohiko Kimura</searchLink><br /><searchLink fieldCode="AR" term="%22Masashi+Shimoda%22">Masashi Shimoda</searchLink><br /><searchLink fieldCode="AR" term="%22Atsushi+Obata%22">Atsushi Obata</searchLink><br /><searchLink fieldCode="AR" term="%22Junpei+Sanada%22">Junpei Sanada</searchLink><br /><searchLink fieldCode="AR" term="%22Yoshiro+Fushimi%22">Yoshiro Fushimi</searchLink><br /><searchLink fieldCode="AR" term="%22Shuhei+Nakanishi%22">Shuhei Nakanishi</searchLink><br /><searchLink fieldCode="AR" term="%22Tomoatsu+Mune%22">Tomoatsu Mune</searchLink><br /><searchLink fieldCode="AR" term="%22Kohei+Kaku%22">Kohei Kaku</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => International Journal of Molecular Sciences; Volume 22; Issue 15; Pages: 7917 ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Multidisciplinary Digital Publishing Institute ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2021 ) Array ( [Name] => Subset [Label] => Collection [Group] => HoldingsInfo [Data] => MDPI Open Access Publishing ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22pancreatic+β-cells%22">pancreatic β-cells</searchLink><br /><searchLink fieldCode="DE" term="%22glucose+toxicity%22">glucose toxicity</searchLink><br /><searchLink fieldCode="DE" term="%22arteriosclerosis%22">arteriosclerosis</searchLink><br /><searchLink fieldCode="DE" term="%22GLP-1+receptor+agonist%22">GLP-1 receptor agonist</searchLink><br /><searchLink fieldCode="DE" term="%22incretin-based+medicine%22">incretin-based medicine</searchLink> ) Array ( [Name] => Subject [Label] => Subject Geographic [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22agris%22">agris</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Fundamental pancreatic β-cell function is to produce and secrete insulin in response to blood glucose levels. However, when β-cells are chronically exposed to hyperglycemia in type 2 diabetes mellitus (T2DM), insulin biosynthesis and secretion are decreased together with reduced expression of insulin transcription factors. Glucagon-like peptide-1 (GLP-1) plays a crucial role in pancreatic β-cells; GLP-1 binds to the GLP-1 receptor (GLP-1R) in the β-cell membrane and thereby enhances insulin secretion, suppresses apoptotic cell death and increase proliferation of β-cells. However, GLP-1R expression in β-cells is reduced under diabetic conditions and thus the GLP-1R activator (GLP-1RA) shows more favorable effects on β-cells at an early stage of T2DM compared to an advanced stage. On the other hand, it has been drawing much attention to the idea that GLP-1 signaling is important in arterial cells; GLP-1 increases nitric oxide, which leads to facilitation of vascular relaxation and suppression of arteriosclerosis. However, GLP-1R expression in arterial cells is also reduced under diabetic conditions and thus GLP-1RA shows more protective effects on arteriosclerosis at an early stage of T2DM. Furthermore, it has been reported recently that administration of GLP-1RA leads to the reduction of cardiovascular events in various large-scale clinical trials. Therefore, we think that it would be better to start GLP-1RA at an early stage of T2DM for the prevention of arteriosclerosis and protection of β-cells against glucose toxicity in routine medical care. ) Array ( [Name] => TypeDocument [Label] => Document Type [Group] => TypDoc [Data] => text ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => NoteTitleSource [Label] => Relation [Group] => SrcInfo [Data] => Molecular Endocrinology and Metabolism; https://dx.doi.org/10.3390/ijms22157917 ) Array ( [Name] => DOI [Label] => DOI [Group] => ID [Data] => 10.3390/ijms22157917 ) Array ( [Name] => URL [Label] => Availability [Group] => URL [Data] => https://doi.org/10.3390/ijms22157917 ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => https://creativecommons.org/licenses/by/4.0/ ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsbas.AAB6FE0 ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.3390/ijms22157917
)
)
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => agris
[Type] => general
)
[1] => Array
(
[SubjectFull] => pancreatic β-cells
[Type] => general
)
[2] => Array
(
[SubjectFull] => glucose toxicity
[Type] => general
)
[3] => Array
(
[SubjectFull] => arteriosclerosis
[Type] => general
)
[4] => Array
(
[SubjectFull] => GLP-1 receptor agonist
[Type] => general
)
[5] => Array
(
[SubjectFull] => incretin-based medicine
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Favorable Effects of GLP-1 Receptor Agonist against Pancreatic β-Cell Glucose Toxicity and the Development of Arteriosclerosis: “The Earlier, the Better” in Therapy with Incretin-Based Medicine
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Hideaki Kaneto
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tomohiko Kimura
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Masashi Shimoda
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Atsushi Obata
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Junpei Sanada
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Yoshiro Fushimi
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Shuhei Nakanishi
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tomoatsu Mune
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Kohei Kaku
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2021
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsbas
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsbas.oa
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => International Journal of Molecular Sciences; Volume 22; Issue 15; Pages: 7917
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |